Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.
about
Mitochondrial lipids in neurodegenerationHumoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin UsersEvaluation of the photooxidation of galactosyl- and lactosylceramide by electrospray ionization mass spectrometry.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Integrated molecular landscape of Parkinson's diseaseChanges in the metabolism of sphingolipids after subarachnoid hemorrhage.Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome.Lipid profiling of parkin-mutant human skin fibroblasts.Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysisCeramides And Stress Signalling Intersect With Autophagic Defects In Neurodegenerative Drosophila blue cheese (bchs) Mutants.Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide speciesPlasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathologyInterferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.Lipidomics of Alzheimer's disease.Genetic convergence of Parkinson's disease and lysosomal storage disorders.The influence of vascular risk factors on cognitive function in early Parkinson's disease.Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment.Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controlsPlasma sphingolipids and depressive symptoms in coronary artery disease.High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients.Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry.A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise.Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans.Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's diseaseEvaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration
P2860
Q28397548-99B7A46A-2102-47E8-9E77-4C9047D70ACDQ28552355-F96B7047-D5A3-4613-A77B-C53506113154Q30857220-4B5A61D1-EDC4-4C0A-9CE8-71893DCFAF23Q31097119-4395D20F-89CB-425C-ACCA-43BB72FDA1A3Q33767544-0AD83B76-1CAE-49F7-9D88-AF111EF45446Q35175609-3E738129-6FEB-4BB2-986A-000D8F87342FQ36088639-E61CE137-962E-415F-A1C7-AF38C034D4E4Q36209750-7485FBEF-E753-4E4A-B7EA-913A37A0AECCQ36256274-1F382032-D66B-47B2-8FB6-FDF283EA6124Q36284241-E2A868FC-99FF-42D2-A82A-743EAA86A23EQ36350326-CCA8AE33-1EF4-42D5-ADFB-3BE684BA8339Q36409995-4A5F9A2E-F8CE-4688-BF4D-DC52E1B94BB7Q36855949-71682F27-542A-4907-86C7-CE6709D2EBAFQ37389500-3772A82D-46CE-4F73-9D60-1EEF3A6FBBDEQ37596791-C5AC4E5A-7CB2-42CB-B2F0-A586952AE383Q38191024-96D177D3-D944-4ED7-B42D-2D9C9683E537Q38237560-16D02DA4-753C-46D6-838F-2189F3387E0BQ38376727-8C2A2AED-BE1C-4A18-9525-978F8878DEFDQ38607507-F74B353E-5482-487A-A3ED-024F1DA3CB14Q38811401-9D45D310-75C6-4766-A55B-B932E614B60FQ41992235-1C632D08-5BF9-44FE-AD63-4676524A8624Q46248790-0CDEF341-6F3A-485D-B010-F860EABD8EC6Q46264470-E0083F5B-38E3-4EDF-8009-120B6B2C203EQ46426783-3BED6C1F-4D47-4EFE-BC4D-EE9B85494FB1Q46694997-BCAD152B-F56C-4F7F-8FCB-FC66D3B37982Q47146081-BE187D95-C78A-4521-9FEB-C72FE10FFD54Q50481966-51E69CE6-5C92-41A9-8870-D48C161E026BQ51761574-2F8A4976-140C-4172-9F30-2FAB1F3A7D99Q55451028-60D0600D-7273-4799-B8DE-A0C518A824D1Q58603525-644737DE-1414-41EF-BF79-11EA2E23879AQ58803874-B51669CC-01F3-426F-903E-6E031C82786A
P2860
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@ast
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@en
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@nl
type
label
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@ast
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@en
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@nl
prefLabel
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@ast
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@en
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@nl
P2093
P2860
P50
P1433
P1476
Plasma ceramide and glucosylce ...... ive impairment: a pilot study.
@en
P2093
Ann-Kathrin Hauser
Christian Deuschle
Erwin Schleicher
Michelle M Mielke
Norman J Haughey
Rodolfo Savica
Susanne Gräber-Sultan
Veera V R Bandaru
P2860
P304
P356
10.1371/JOURNAL.PONE.0073094
P407
P577
2013-09-18T00:00:00Z